64P Assessment of clinical benefit of cancer drugs recommended in National Comprehensive Cancer Centre (NCCN) guidelines for advanced gastrointestinal stromal tumors (GIST)
| Autor: | Lleida, R. Teres, Sorolla, M. Aguado, Cardozo, A. Romano, Bosma, F., Del Rio, S. Sanchez, Piedra, A., Tibau, A., Garcia, A. Sebio |
|---|---|
| Zdroj: | In ESMO Open March 2024 9 Supplement 2 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|